CRO concept sector is active, Chengda Pharmaceutical leads the gains

March 31 news, as of 13:50, the CRO concept sector is active. Kelaiying is up to its daily limit, while stocks including Chengda Pharmaceutical, Nuo Si Ge, Zhaoyan New Drug, and Kanglong Huicheng are leading the gainers.

Statement: The market involves risk; investment requires caution. This article is automatically published based on third-party databases and does not represent the views of Sina Finance. Any information appearing in this article is for reference only and does not constitute personal investment advice. If there is any discrepancy, please refer to the actual announcements. If you have any questions, please contact biz@staff.sina.com.cn.

A wealth of information and precise analysis—find it all on the Sina Finance app

Editor: Xiaolang Express

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin